Serina Therapeutics Inc.

5.42
0.13 (2.46%)
At close: Mar 31, 2025, 3:58 PM
6.00
10.70%
After-hours: Mar 31, 2025, 05:45 PM EDT

Serina Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
PE Ratio n/a -7.82 -7.93 -33.16 -5.35 -5.67 -14.13 -14.99 -6.36
PEG Ratio n/a 0.27 -0.07 0.37 0.46 -0.11 -0.83 0.26 n/a
PS Ratio n/a 814.73 42.53 13.80 1.08K 39.86 75.94 70.23 59.19
PB Ratio n/a 21.15 -0.56 -1.19 -11.37 31.06 14.24 13.54 -4.21
P/FCF Ratio n/a -14.83 -10.2 -17.78 -7.42 -6.38 -10.72 -15.69 -11.67
P/OCF Ratio n/a -14.83 -10.25 -18.63 -7.44 -6.78 -13.26 -15.69 -11.7
OCF/S Ratio n/a -54.93 -4.15 -0.74 -144.76 -5.88 -5.73 -4.48 -5.06
Debt / Equity Ratio 0.42 0.80 -0.05 -0.01 -1.23 0.88 n/a n/a n/a
Quick Ratio 2.40 0.13 5.35 7.91 0.43 1.23 3.22 5.79 0.03
Current Ratio 2.40 0.13 1.25 3.58 0.43 1.23 3.22 5.79 0.03
Asset Turnover n/a 0.01 0.58 1.65 0.01 0.23 0.13 0.15 0.52
Interest Coverage n/a -17.85 -142.99 -527.31 -25.76 n/a n/a -701.42 -509.56
Return on Equity (ROE) n/a -2.71 0.07 0.04 2.12 -5.48 -1.01 -0.9 0.66
Return on Assets (ROA) n/a -1.24 -3.13 -0.69 -2.77 -1.63 -0.7 -0.68 -4.81
Return on Capital (ROIC) n/a -1.65 -5.4 -1.11 7.27 -3.03 -1.27 -1.01 0.57
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a -20.42% 71.00% 95.06% -2.27K% 42.22% 39.76% 51.21% 0.45%
Net Profit Margin n/a -10.42K% -536.42% -41.61% -20.12K% -703.36% -537.39% -468.66% -9.3%
Pretax Profit Margin n/a -10.43K% -536.42% -41.61% -19.26K% -708.1% -553.8% -472.72% -10.42%
Operating Profit Margin n/a -7.01K% -454.07% -53.68% -19.27K% -726.79% -748.21% -599.5% -7.65%
FCF Margin -12.08K% -1.56K% -68.61% -4.37K% -453.53% -773.71% -704.27% -377.31% n/a
EBITDA Margin -6.89K% -520.99% -52.23% -16.19K% -671.76% -515.47% -550.93% -713.93% n/a